Hunter Shkolnik Comments on Proposed Opioid Settlement
December 5, 2019
Source: Daily Stock Dish
Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.
The deal is “overvalued to make the settlement look better,” said Hunter Shkolnik, a lawyer on the plaintiffs executive committee that is managing more than 2,300 federal lawsuits consolidated in the U.S. District Court in Cleveland.
“I don’t believe a no-cash payment from Teva, one of the largest generic manufacturers in the world, is appropriate,” he told Reuters.
Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors, AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp.
Download
Featured Attorneys
Related Articles
Uloric Lawsuit Claims and Process
May 20, 2019
We trust our doctors and trained medical professionals to take care of us and recommended medications that will keep us safe and healthy and that won’t end up causing more harm than good. Unfortunately, more and more often these days, medications are being shown to have known risks and dangers associated with them. Many of…Read the article
Marie Napoli Honored by her Alma Mater
April 27, 2017
Marie Napoli was recently recognized by the St. John’s University Board of Trustees for her ongoing commitment and professional contributions to the University. In her remarks, Marie commented on her long history with St. John’s. In a lucky twist of fate, the institution lead to her parent’s meeting! Marie would go on to study at…Read the article